Virtual health insurance navigation for young adult cancer survivors
Official title: A Randomized Controlled Trial to Improve Health Insurance Literacy and Surveillance Among Young Adult Cancer Survivors
Run by University of Utah · NCT05829070 · Data updated 2026-11-12
This trial will test a four-session virtual program to help 26–39-year-old cancer survivors understand their health insurance, reduce financial strain, and improve follow-up surveillance.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 26 Years to 45 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | University of Utah Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Murray, Utah and 1 other locations) |
| Status | Recruiting |
| Started | November 8, 2023 |
| Main results expected | October 2027 |
| Study ends | March 2028 |
| Registry record updated | April 28, 2026 |
| Trial ID | NCT05829070 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 26–45 (preferably 26–39) diagnosed with breast, testicular, lymphoma, sarcoma, or colorectal cancer who completed initial treatment within the past year, are patients at University of Utah/Huntsman or Intermountain Healthcare, and speak English.
✕Probably not a fit
People who do not speak English, lack phone or video-capable devices, have developmental delays that prevent participation, live outside the participating health systems, or have cancer types not listed are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial will enroll 300 young adult cancer survivors to compare a four-session virtual navigation program (CHAT-S) with usual care. The intervention delivers guided health insurance education and navigation remotely to improve insurance knowledge and help survivors access recommended survivorship services. Outcomes will be measured using self-report surveys combined with electronic health records and claims data to capture insurance knowledge, financial burden, and surveillance for recurrence. An economic evaluation including cost-effectiveness and budget impact analyses will examine sustainability and potential system-level value.
Why it matters
Potential benefit: If successful, the program could help young survivors better use their insurance, face lower out-of-pocket costs, and be more likely to receive guideline-recommended surveillance.
How similar studies have gone: Pilot implementations of this navigation program and an adapted childhood-survivor version demonstrated feasibility, acceptability, and preliminary efficacy, but large randomized evidence is still pending.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants are eligible for this study if they: 1. Were diagnosed with breast, testicular, lymphoma, sarcoma, and colorectal cancer, 2. Are between the ages of 26 to 45 years (preferably between 26-39, but no older than 45), 3. Have completed initial treatment (i.e., radiation, chemotherapy, or surgery) within the past year, 4. Are a patient at the University of Utah/Huntsman Cancer Institute or Intermountain Healthcare, and 5. Speak English. Exclusion Criteria: Potential participants will be excluded if they: 1. Are unable to participate due to developmental delay, and 2. Speak a language other than English, and 3. Unable to participate through either phone or a video capable computer or mobile device (e.g., smartphone, laptop, etc.).
Where it's running
-
Intermountain Health
Murray, Utah, United States Recruiting -
University of Utah
Salt Lake City, Utah, United States Recruiting
Study contacts
- Study coordinator: Amy Chevrier, BS
- Email: amy.chevrier@hci.utah.edu
- Phone: 8018881803
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.